World Health Organization. HIV/AIDS. 2019. https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Accessed 11 Nov 2019.
Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Heal. 2017;5:e1192–207.
Arendt V, Guillorit L, Origer A, Sauvageot N, Vaillant M, Fischer A, et al. Injection of cocaine is associated with a recent HIV outbreak in people who inject drugs in Luxembourg. PLoS One. 2019;14:e0215570.
Giese C, Igoe D, Gibbons Z, Hurley C, Stokes S, McNamara S, et al. Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland, 2015. Euro Surveill. 2015;20:30036.
McAuley A, Palmateer NE, Goldberg DJ, Trayner KMA, Shepherd SJ, Gunson RN, et al. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. Lancet HIV. 2019;6:e315–24.
Pharris A, Wiessing L, Sfetcu O, Hedrich D, Botescu A, Fotiou A, et al. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Euro Surveill. 2011;16 http://www.ncbi.nlm.nih.gov/pubmed/22172301. Accessed 1 Sep 2017.
Ragonnet-Cronin M, Jackson C, Bradley-Stewart A, Aitken C, McAuley A, Palmateer N, et al. Recent and rapid transmission of HIV among people who inject drugs in Scotland revealed through phylogenetic analysis. J Infect Dis. 2018;217:1875–82.
Campbell EM, Jia H, Shankar A, Hanson D, Luo W, Masciotra S, et al. Detailed transmission network analysis of a large opiate-driven outbreak of HIV infection in the United States. J Infect Dis. 2017;216:1053–62.
Nikolopoulos G, Paraskevis D, Hatzakis A. HIV epidemiology in Greece. Future Microbiol. 2008;3:507–16.
Nikolopoulos GK, Sypsa V, Bonovas S, Paraskevis D, Malliori-Minerva M, Hatzakis A, et al. Big events in Greece and HIV infection among people who inject drugs. Subst Use Misuse. 2015;50:825–38.
Nikolopoulos GK, Fotiou A, Kanavou E, Richardson C, Detsis M, Pharris A, et al. National income inequality and declining GDP growth rates are associated with increases in HIV diagnoses among people who inject drugs in Europe: a panel data analysis. PLoS One. 2015;10:e0122367.
Hatzakis A, Sypsa V, Paraskevis D, Nikolopoulos G, Tsiara C, Micha K, et al. Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme. Addiction. 2015;110:1453–67.
Sypsa V, Paraskevis D, Malliori M, Nikolopoulos GK, Panopoulos A, Kantzanou M, et al. Homelessness and other risk factors for HIV infection in the current outbreak among injection drug users in Athens, Greece. Am J Public Health. 2015;105:196–204.
Sypsa V, Psichogiou M, Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, et al. Rapid decline in HIV incidence among persons who inject drugs during a fast-track combination prevention program after an HIV outbreak in Athens. J Infect Dis. 2017;215:1496–505.
Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39:446–53.
Schlumberger MG, Desenclos JC, Papaevangelou G, Richardson SC, Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European community study group on HIV in injecting drug users. Eur J Epidemiol. 1999;15:207–15.
Grau LE, White E, Niccolai LM, Toussova OV, Verevochkin SV, Kozlov AP, et al. HIV disclosure, condom use, and awareness of HIV infection among HIV-positive, heterosexual drug injectors in St. Petersburg, Russian Federation. AIDS Behav. 2011;15:45–57.
Mazhnaya A, Andreeva TI, Samuels S, DeHovitz J, Salyuk T, McNutt L-A. The potential for bridging: HIV status awareness and risky sexual behaviour of injection drug users who have non-injecting permanent partners in Ukraine. J Int AIDS Soc. 2014;17:18825.
Heimer R, Levina OS, Osipenko V, Ruiz MS, Sergeyev B, Sirotkin AV, et al. Impact of incarceration experiences on reported HIV status and associated risk behaviours and disease comorbidities. Eur J Pub Health. 2015;25:1089–94.
Abel-Ollo K, Rahu M, Rajaleid K, Talu A, Rüütel K, Platt L, et al. Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia. AIDS Care. 2009;21:851–7.
Rhodes T, Donoghoe M, Hunter G, Stimson G. Continued risk behaviour among HIV positive drug injectors in London: implications for intervention. Addiction. 1993;88:1553–60.
Avants SK, Warburton LA, Hawkins KA, Margolin A. Continuation of high-risk behavior by HIV-positive drug users: treatment implications. J Subst Abus Treat. 2000;19:15–22.
Noor SW, Ross MW, Lai D, Risser JM. Drug and sexual HIV risk behaviours related to knowledge of HIV serostatus among injection drug users in Houston, Texas. Int J STD AIDS. 2014;25:89–95.
Bruneau J, Zang G, Abrahamowicz M, Jutras-Aswad D, Daniel M, Roy E. Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study. Clin Infect Dis. 2014;58:755–61.
Aspinall EJ, Weir A, Sacks-Davis R, Spelman T, Grebely J, Higgs P, et al. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the networks II study. Int J Drug Policy. 2014;25:179–82.
Chan PA, Flanigan TP. Effective HIV prevention interventions and the need for rapid mobilization to address HIV outbreaks among at-risk populations. J Infect Dis. 2017;215:1491–2.
Gallagher KM, Sullivan PS, Lansky A, Onorato IM. Behavioral Surveillance among People at Risk for HIV Infection in the U.S.: The National HIV Behavioral Surveillance System. Public Health Rep. 2007;122(1_suppl):32–8.
Aktas Samur A, Coskunfirat N, Saka O. Comparison of predictor approaches for longitudinal binary outcomes: application to anesthesiology data. PeerJ. 2014;2:e648.
Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.
Huh D, Flaherty BP, Simoni JM. Optimizing the analysis of adherence interventions using logistic generalized estimating equations. AIDS Behav. 2012;16:422–31.
StataCorp. Stata Statistical Software Release 11.1. Texas: StataCorp LP Coll Stn; 2009.
Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction. 2006;101:252–66.
Niccolai LM, Toussova OV, Verevochkin SV, Barbour R, Heimer R, Kozlov AP. High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive Serostatus among injection drug users in St. Petersburg, Russia. AIDS Behav. 2010;14:932–41.
Solomon SS, McFall AM, Lucas GM, Srikrishnan AK, Kumar MS, Anand S, et al. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: a cross-sectional, community-based analysis. PLoS Med. 2017;14:e1002460.
Smith LR, Patterson TL, Magis-Rodriguez C, Ojeda VD, Burgos JL, Rojas SA, et al. Engagement in the HIV care continuum among key populations in Tijuana, Mexico. AIDS Behav. 2016;20:1017–25.
Mehta SH, Lucas GM, Solomon S, Srikrishnan AK, McFall AM, Dhingra N, et al. HIV Care Continuum Among Men Who Have Sex With Men and Persons Who Inject Drugs in India: Barriers to Successful Engagement. Clin Infect Dis. 2015;61:civ669.
Abadie R, Goldenberg S, Welch-Lazoritz M, Fisher CB. Establishing trust in HIV/HCV research among people who inject drugs (PWID): insights from empirical research. PLoS One. 2018;13:e0208410.
Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, et al. HIV Infection and Risk, Prevention, and Testing Behaviors Among Injecting Drug Users — National HIV Behavioral Surveillance System, 20 U.S. Cities, 2009. Morbidity and Mortality Weekly Report: Surveill Summaries. 2014;63:1–51.
Qian H-Z, Schumacher J, Chen H, Ruan Y-H. Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications. Harm Reduct J. 2006;3:4.
Balabanova Y, Coker R, Atun RA, Drobniewski F. Stigma and HIV infection in Russia. AIDS Care. 2006;18:846–52.
Cooke A, Saleem H, Mushi D, Mbwambo J, Hassan S, Lambdin BH. Convenience without disclosure: a formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar Es Salaam, Tanzania. Addict Sci Clin Pract. 2017;12:23.
Nikolopoulos G, Pavlitina E, Muth SSQ, Schneider J, Psichogiou M, Williams LLD, et al. A network intervention that locates and intervenes with recently HIV-infected persons: The Transmission Reduction Intervention Project (TRIP). Sci Rep. 2016;6:38100.
Terlikbayeva A, Zhussupov B, Primbetova S, Gilbert L, Atabekov N, Giyasova G, et al. Access to HIV counseling and testing among people who inject drugs in Central Asia: strategies for improving access and linkages to treatment and care. Drug Alcohol Depend. 2013;132:S61–4.
Ti L, Hayashi K, Hattirat S, Suwannawong P, Kaplan K, Kerr T. ‘Drug users stick together’: HIV testing in peer-based drop-in centres among people who inject drugs in Thailand. Sex Health. 2015;12:263.
Ahmed T, Long TN, Huong PT, Stewart DE. Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis. BMC Public Health. 2015;15:32.
Kumar S, Gupte HA, Isaakidis P, Mishra JK, Munjattu JF. “They don’t like us … .”: Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study. PLoS One. 2018;13:e0203262.
Noroozi A, Mirzazadeh A, Farhoudian A, Hajebi A, Khankeh HR, Higgs P, et al. Impact of HIV status notification on risk behaviors among men who inject drugs in Kermanshah, west of Iran. J Res Health Sci. 2016;16:116–21.
Armstrong G, Medhi GK, Mahanta J, Paranjape RS, Armstrong G, Medhi GK, et al. Undiagnosed HIV among people who inject drugs in Manipur , India. AIDS Care. 2015;27:288–92.
Rosenberg NE, Pettifor AE, De Bruyn G, Westreich D, Delany-Moretlwe S, Behets F, et al. HIV testing and counseling leads to immediate consistent condom use among south African stable HIV-discordant couples. J Acquir Immune Defic Syndr. 2013;62:226–33.
Turner AN, Miller WC, Padian NS, Kaufman JS, Behets FM, Chipato T, et al. Unprotected sex following HIV testing among women in Uganda and Zimbabwe: short- and long-term comparisons with pre-test behaviour. Int J Epidemiol. 2009;38:997–1007.
Kalichman SC, Price D, Eaton LA, Burnham K, Sullivan M, Finneran S, et al. Diminishing perceived threat of AIDS and increasing sexual risks of HIV among men who have sex with men, 1997–2015. Arch Sex Behav. 2017;46:895–902.
Chen Y. Treatment-related optimistic beliefs and risk of HIV transmission: a review of recent findings (2009-2012) in an era of treatment as prevention. Curr HIV/AIDS Rep. 2013;10:79–88.
Chamratrithirong A, Kaiser P. The dynamics of condom use with regular and casual partners: analysis of the 2006 National Sexual Behavior Survey of Thailand. PLoS One. 2012;7:e42009.
Bouhnik A-D, Préau M, Lert F, Peretti-Watel P, Schiltz M-A, Obadia Y, et al. Unsafe sex in regular partnerships among heterosexual persons living with HIV: evidence from a large representative sample of individuals attending outpatients services in France (ANRS-EN12-VESPA study). AIDS. 2007;21(Suppl 1):S57–62.
Gorbach PM, Drumright LN, Daar ES, Little SJ. Transmission behaviors of recently HIV-infected men who have sex with men. JAIDS J Acquir Immune Defic Syndr. 2006;42:80–5.
Gorbach PM, Weiss RE, Jeffries R, Javanbakht M, Drumright LN, Daar ES, et al. Behaviors of recently HIV-infected men who have sex with men in the year postdiagnosis: effects of drug use and partner types. J Acquir Immune Defic Syndr. 2011;56:176–82.
Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet. 1999;353:1657–61.
Des Jarlais DC, Friedmann P, Hagan H, Friedman SR. The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. WHO multi-Centre study of AIDS and injecting drug use. Am J Public Health. 1996;86:1780–5.
Magura S, Goldsmith D, Casriel C, Goldstein PJ, Lipton DS. The validity of methadone clients’ self-reported drug use. Int J Addict. 1987;22:727–49.
Colchero MA, Bautista-Arredondo S, Cortés-Ortiz MA, Romero-Martinez M, Salas J, Sosa-Rubí SG, et al. Impact and economic evaluations of a combination prevention programme for men who have sex with men in Mexico. AIDS. 2016;30:293–300.
Paraskevis D, Paraschiv S, Sypsa V, Nikolopoulos G, Tsiara C, Magiorkinis G, et al. Enhanced HIV-1 surveillance using molecular epidemiology to study and monitor HIV-1 outbreaks among intravenous drug users (IDUs) in Athens and Bucharest. Infect Genet Evol. 2015;35:109–21.
Des Jarlais D, Sypsa V, Feelemyer J, Abagiu A, Arendt V, Devaux C. Complacency is the new problem: Comparative Analysis of Recent Outbreaks of HIV among Persons Who Inject Drugs in Europe and North America. In: 22nd International AIDS Conference. Amsterdam; 2018. Available online at http://www.aids2018.org/Portals/4/File/AIDS2018_Abstract_book.pdf?ver=2018-08-06-160624-427